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osting by EAbstract This study was aimed to assess the pulmonary function tests (PFTs) in cardiac patients;
with ischemic or rheumatic heart diseases as well as in patients who underwent coronary artery
bypass graft (CABG) or valvular procedures. For the forty eligible participants, the pulmonary
function was measured using the spirometry test before and after the cardiac surgery. Data collec-
tion sheet was used for the patient’s demographic and intra-operative information. Cardiac diseases
and surgeries had restrictive negative impact on PFTs. Before surgery, vital capacity (VC), forced
vital capacity (FVC), forced expiratory volume in the ﬁrst second (FEV1), ratio between FEV1 and
FVC, and maximum voluntary ventilation (MVV) recorded lower values for rheumatic patients
than ischemic patients (P values were 0.01, 0.005, 0.0001, 0.031, and 0.035, respectively). Moreover,
patients who underwent valvular surgery had lower PFTs than patients who underwent CABG with
signiﬁcant differences for VC, FVC, FEV1, and MVV tests (P values were 0.043, 0.011, 0.040, and
0.020, respectively). No deﬁnite causative factor appeared to be responsible for those results
although mechanical deﬁciency and incisional chest pain caused by cardiac surgery are doubtful.
More comprehensive investigation is required to resolve the case.
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lsevier1. Introduction
Impaired pulmonary function is common in cardiac patients
(Shnkman et al., 1997). Respiratory muscle wasting has been
well documented in mitral stenosis (Saxena et al., 2007). Fur-
thermore, it was found that pulmonary impairment is more
frequent after cardiac surgery than after other major surgical
procedures (Bund et al., 1998). Deterioration in pulmonary
function is a common complication following CABG surgery
and there is still speculation to the precise causative factors
thereof (Kleinloog and McFarlane, 2007).
The current study aimed to assess the PFTs of cardiac
patient; with ischemic or rheumatic heart diseases as well as
patients who underwent CABG or valvular procedures. The
main objective of this study is to describe the pattern of
82 S.B. El-Sobkey, M. Gomaapulmonary function complications and to critically appraise
the possible causative factors.2. Method
This study was conducted at the Cardiothoracic Surgery
Department of the educational hospital of Cairo University.
Forty volunteer patients participated in this study; 18 females
(45%) and 22 males (55%) with mean age of (44.0 ±
15.8 years). Patients with rheumatic heart disease (RHD) were
21 (52.5%) while patients with ischemic heart disease (IHD)
were 19 (47.5%). They were scheduled for cardiac surgery, val-
vular and CABG, respectively.
Volunteer patients, who met the inclusion criteria, signed a
consent form after they got a clear explanation of the spirom-
etry evaluation procedures. Inclusion criteria included; adult
cardiac patient with valvular or ischemic heart disease sched-
uled for primary cardiac surgery, long life non-smokers or
those who quit smoking, had no learning barriers to follow
the instructions required to carry out the spirometry test,
and were free from diabetes mellitus or neurological disorders
and were not diagnosed as respiratory diseased patients. DataTable 1 Characteristics of patients participated in the current stud
Demographic characteristics Valvular surgery
N Mean ± SD
Age (year) 21 32.2 ± 11.2
N (%)
Gender
Female 14 (66.7)
Male 7 (33.3)
Total 21 (100)
Smoking habit
Long life non-smoker 19 (90.5)
Quit smoking 2 (9.5)
Total 21 (100)
Residence
Urban 6 (28.6)
Rural 15 (71.4)
Total 21 (100)
Intra-operative N Mean
Cardiopulmonary bypass time (min) 21 102.2 ±
Cardiac ischemic time (min) 21 67.4 ±
Body core temperature (C) 21 29.2 ±
N (%)
Cardioplegia
Cold 14 (66.7)
Warm 7 (33.3)
Total 21 (100)
Topical cooling
Ice slush 8 (38.1)
Cold saline 6 (28.6)
Non 7 (33.3)
Total 21 (100)collection sheet was used to gather personal, medical and sur-
gical information.
2.1. Main outcome measure
By using a portable computerized spirometer, PFTs were con-
ducted twice, 2 days before the surgery and 7–10 days after the
surgery when the patient’s condition allowed it as reported by
the cardiac surgeon. The following PFTs were measured; vital
capacity (VC), forced vital capacity (FVC), forced expiratory
volume in the ﬁrst second (FEV1), ratio between forced expi-
ratory volume in the ﬁrst second and forced vital capacity
(FEV1/FVC), and maximum voluntary ventilation (MVV).
These measured pulmonary function values were presented
as a percentage from the predictive values, which were com-
puted according to the patient’s age, sex, weight and height
and were considered normal if they wereP80% of the predic-
tive values. Pulmonary function complications’ patterns were
described as restrictive or obstructive according to the follow-
ing case deﬁnition. A restrictive pattern was considered when:
VC and FEV1 are reduced but the ratio of FEV1/FVC is nor-
mal, while an obstructive pattern was considered when: VC is
normal and FEV1 and the ratio of FEV1/FVC are reduced.y.
CABG surgery P
N Mean ± SD
19 57.0 ± 8.1 0.0001
N (%) P
4 (21.1) 0.010
15 (78.9)
19 (100)
5 (26.3) 0.0001
14 (73.7)
19 (100)
12 (63.2) 0.030
7 (36.8)
19 (100)
± SD N Mean ± SD P
26.9 19 99.5 ± 25.7 0.752
20.1 19 65.6 ± 22.6 0.792
2.8 19 33.8 ± 1.1 0.0001
N (%) P
1 (5.3) 0.0001
18 (94.7)
19 (100)
1 (5.3) 0.0001
0 (0)
18 (94.7)
19 (100)
Figure 1 Before and after valvular and CABG surgeries mean
values of pulmonary function tests.
Figure 2 After valvular and CABG surgeries mean values of
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Independent t-tests were used to compare the means of PFTs
between rheumatic and ischemic heart disease patients both
before and after the cardiac surgery. Paired t-tests were used
to compare the means of PFTs before and after valvular sur-
gery as well as CABG surgery. In addition, parametric corre-
lation tests were used to examine the association between
PFTs and cardiopulmonary bypass time, cardiac ischemic
time, core body temperature and patient’s age. While non-
parametric correlation tests were used to examine the associa-
tion between PFTs and the type of used cardioplegia, topical
cooling, patient’s gender, smoking habit and residence. Each
of the intra-operative factors or demographic factors was
examined as a univariate. SPSS version 10 was used. P values
<0.05 were considered signiﬁcant.
3. Results
Table 1 presented characteristics of the 40 participated pa-
tients. It showed that RHD patients are mostly young females
(mean age of 32.2 ± 11.2 years) who lived in rural areas and
were long life non-smokers. While patients with IHD were old-
er males (mean age of 57.0 ± 8.1 years) who lived in urban
areas and quitted smoking before hospital admission by
1 month to 2 years.
Even before surgery, rheumatic and ischemic cardiac pa-
tients had below normal values of PFTs of restrictive pattern
and it was noticeable that patients with RHD had lower values
than patients with IHD (Table 2).
Results also showed that cardiac surgery was followed by
pulmonary complications in the form of further deterioration
on PFTs. This negative impact on pulmonary function was
true for both valvular and CABG surgeries. Regardless of
the surgery type, patients had lower values of PFTs after the
surgery than before it. Those lower values were of statistical
signiﬁcance for all PFTs for both valvular and CABG surger-
ies. The only exception was FEV1/FVC test, which increased
after valvular surgery and lowered after CABG surgery with-
out statistical signiﬁcance (Fig. 1a and b).
In addition, results showed that patients who underwent val-
vular surgery had signiﬁcant lower values of PFTs than patients
who underwent CABG surgery. This was applied for the follow-
ing tests, VC, FVC, FEV1, and MVV (P values were 0.043,
0.011, 0.040, and 0.020, respectively). FEV1/FVC parameterTable 2 Before cardiac surgery pulmonary function tests
values for RHD and IHD patients.
Pulmonary function tests Diagnosis N Mean ± SD P
VC RHD 21 46.9 ± 13.6 0.01
IHD 19 57.3 ± 10.1
FVC RHD 21 43.5 ± 11.8 0.005
IHD 19 54.9 ± 12.0
FEV1 RHD 20 44.6 ± 13.2 0.0001
IHD 19 62.5 ± 13.9
FEV1/FVC RHD 20 102.5 ± 19.9 0.031
IHD 19 113.8 ± 9.5
MVV RHD 20 30.9 ± 10.6 0.035
IHD 19 38.8 ± 11.9
pulmonary function tests.was lower in patients who underwent valvular surgery than
those who underwent CABG but without statistical signiﬁcance
(Fig. 2).
Analysis of the intra-operative data (Table 1) showed that
in valvular surgery, the cardiac ischemic time and cardiopul-
monary bypass time were longer than those of the CABG sur-
gery but without signiﬁcance difference. On the other hand,
patient’s core body temperature in valvular surgery was signif-
icantly lower than that in patients with CABG surgery
(29.2 ± 2.8 and 33.8 ± 1.1, respectively, P< 0.0001). Cold
cardioplegia was used in most of the valvular surgeries
(66.7%) while in the majority of the CABG surgeries
(94.7%) warm cardioplegia was used. In valvular surgery, ice
slush was usually used as a topical cooling (38.1%) but in
Table 3 After cardiac surgery correlation between intra-
operative factors and pulmonary function tests.
Pulmonary
function test after
cardiac surgery
Intra-operative factors N r P
VC Cardiopulmonary bypass time 35 0.105 0.548
Cardiac ischemic time 0.185 0.287
Cardioplegia 0.27 0.137
Topical cooling 0.281 0.102
Core body temperature 0.273 0.113
FVC Cardiopulmonary bypass time 39 0.161 0.327
Cardiac ischemic time 0.219 0.181
Cardioplegia 0.265 0.103
Topical cooling 0.265 0.104
Core body temperature 0.29 0.073
FEV1 Cardiopulmonary bypass time 37 0.192 0.256
Cardiac ischemic time 0.247 0.141
Cardioplegia 0.17 0.331
Topical cooling 0.161 0.34
Core body temperature 0.175 0.301
FEV1/FVC Cardiopulmonary bypass time 37 0.24 0.152
Cardiac ischemic time 0.35 0.032
Cardioplegia 0.298 0.074
Topical cooling 0.302 0.069
Core body temperature 0.077 0.65
MVV Cardiopulmonary bypass time 37 0.156 0.356
Cardiac ischemic time 0.195 0.248
Cardioplegia 0.301 0.070
Topical cooling 0.308 0.064
Core body temperature 0.288 0.084
Table 4 After cardiac surgery correlation between the
patients’ demographic characters and their pulmonary function
tests.
Pulmonary function
tests after
cardiac surgery
Demographic
characters
N r P
VC Age 35 0.389 0.021
Gender 0.119 0.497
Smoking habit 0.097 0.581
Residence 0.171 0.871
FVC Age 39 0.448 0.004
Gender 0.017 0.919
Smoking habit 0.07 0.674
Residence 0.067 0.686
FEV1 Age 37 0.326 0.049
Gender 0.069 0.687
Smoking habit 0.043 0.798
Residence 0.069 0.685
FEV1/FVC Age 37 0.026 0.877
Gender 0.067 0.692
Smoking habit 0.392 0.016
Residence 0.01 0.556
MVV Age 37 0.41 0.012
Gender 0.177 0.296
Smoking habit 0.233 0.166
Residence 0.0107 0.529
84 S.B. El-Sobkey, M. Gomaathe CABG surgery, it was common not to use any topical cool-
ing modality (94.7%). Although there were different intra-
operative situations among the valvular and CABG surgeries,there was no correlative relation between any of the studied in-
tra-operative factors and PFTs values after the surgery. The
only exception for that is the negative signiﬁcant correlation
between cardiac ischemic time and FEV1/FVC test (Table 3).
The correlations between patients’ age and their PFTs after
cardiac surgery were signiﬁcantly positive. The older the pa-
tient, the better the values of all PFTs except for FEV1/FVC
test. The other demographic characters showed no correlation
(Table 4).4. Discussion
This study was accomplished to describe the PFTs complica-
tions accompanying cardiac disease and cardiac surgery and
to detect the underlying causative factors. Spirometry test
had been used as it is an objective, valid and reliable method
to measure the PFTs. In addition, it is a non-invasive method
that can be handled without any inconvenience to the patient
especially after surgery. Chandra et al. (1998), Blonshine and
Fink (2000) and Handojo et al. (2006) agreed with that.
The below normal PFTs values shown before cardiac sur-
gery were similar to Saxena et al. (2007) study’s results. They
found that FVC, FEV1, and peak expiratory ﬂow rates were
universally decreased before surgery in patients with mitral
valve disease. Weissman (1999) also had similar results. It
was noticeable that patients with RHD showed lower values
than patients with IHD. This could be explained pathologi-
cally by the fact that patients with RHD are more common
to develop left ventricular dysfunction with consequent pul-
monary oedema in which the lung compliance is reduced and
the resistance to air ﬂow is increased with the resultant de-
creased gas exchange and decreased pulmonary function.
The decreased pulmonary function was obviously represented
with the spirometry test. The restrictive pattern of this de-
creased pulmonary function predominates this explanation.
Saxena et al. (2007) had a close explanation as they reported
that mitral valve disease has important effects on the pulmon-
ary vasculature. Pulmonary hypertension in these patients usu-
ally results from a combination of transmission of raised left
atrial pressure, pulmonary arteriolar constriction and organic
obliterate changes in the pulmonary vasculature. Pulmonary
dysfunction is attributed to interstitial and alveolar oedema,
reactive ﬁbrosis, previous pulmonary infarctions, pleural effu-
sion and decreased lung volumes with compressive atelectasis.
These changes cause a marked reduction in lung compliance,
an increase in the work of breathing and a redistribution of
pulmonary blood ﬂow from the bases to apices.
Cardiac surgeries are proved to have a negative impact on
pulmonary function. All studied tests; VC, FVC, FEV1,
FEV1/FVC, and MVV had lower values after the surgery than
before it. This was true for both valvular and CABG proce-
dures. Again, the pattern was a restrictive one. These results
are supported by other studies’ results (Shnkman et al., 1997;
Saxena et al., 2007; Weissman, 1999; Stenseth et al., 1996;
Vaidya et al., 1996). The case of lower PFTs values of the
RHD patients than the IHD remained the same after the sur-
gery. Patients who underwent valvular surgery had lower PFTs
values than patients who underwent CABG. This seemed logic;
as long the earlier values (before surgery) were lower, the later
ones (after surgery) would be also lowered. Further, it could
be important to mention that most of the valvular surgery
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males. If it is remembered that females have lower PFTs values
thanmales and they may react to pain worse thanmales it could
be a way to understand why patients in the current study who
underwent valvular surgery had lower pulmonary function than
patients who underwent CABG. Nevertheless, were there any
other factors that make valvular surgery more susceptible to
lower PFTs values rather than the lower before surgery values?
This question had been approached by comparing the intra-
operative factors of valvular and CABG surgeries. As showed
in Table 1, the cardiac ischemic time and cardiopulmonary by-
pass time were longer in patients who underwent valvular sur-
gery than that of patients who underwent CABG but without
a signiﬁcant difference. However, let us not forget that literature
demonstrated the cardiopulmonary bypass as one of the most
accused factor. This is partly because of the inﬂammatory re-
sponse (Mahmoud et al., 2005) it produces in the pulmonary
system and consequent pulmonary dysfunction and partly be-
cause it causes changes in the mechanical behaviour of the lung
that are generally consistent with those caused by pulmonary
oedema (Barnas et al., 1994). In addition to the poor pulmonary
gas exchange it produces after surgery (Kochamba et al., 2000).
Chandra et al. (1998) found a signiﬁcant deterioration in the pre
discharge spirometric values of FVC, FEV1, peak expiratory
ﬂow rate, ﬂow rate at 25–75% of expired vital capacity, and
MVV, which was greater in those who had prolonged cardio-
pulmonary bypass time (more than 80 min). That is why
although the current study showed no signiﬁcant difference in
cardiopulmonary bypass time between the valvular and CABG
surgeries and no correlation between cardiopulmonary bypass
time and the PFTs, this factor should not be completely acquit-
ted and more studies are needed to give a ﬁnal decision.
Current study showed that in most of the valvular surgeries
(66.7%) cold cardioplegia had been used with ice slush as a top-
ical cooling. On the other side, patients who underwent CABG
had mostly used warm cardioplegia (94.7%) without the use of
any topical cooling. This may be claimed to be the cause of low-
er PFTs with valvular surgery and specially mentioned by Sax-
ena et al. (2007) that cardioplegia is a factor that may
contribute to the deteriorated pulmonary function after cardiac
surgery as it may passively enter the pulmonary circulation and
damage the endothelial cells in the lungs due to high potassium
concentration and result in atelectasis. But the correlative anal-
ysis to the PFTs and the above mentioned intra-operative fac-
tors; cardioplegia, topical cooling and core body temperature
were not signiﬁcant. Kleinloog and McFarlane (2007)) sup-
ported these results as they found that cold blood cardioplegia
solution, which circulates in the lungs during cardiopulmonary
bypass does not have any (beneﬁcial or detrimental) effect on
clinical pulmonary function after surgery. One of the current
study limitations is lack in investigating the correlation between
atelectasis and PFTs, which would give clearer picture of pul-
monary complications after cardiac surgery.
Patients who underwent valvular surgery had signiﬁcant
lower core body temperature than patients who underwent
CABG. The effect of this factor on the lower PFTs values after
cardiac surgery can be explained by the fact that low body
temperature decreases the metabolism and functions of differ-
ent body organs and systems so it could also be applied on the
pulmonary system.
Studying the patient’s demographic characteristics was an-
other trial to explain why cardiac surgeries had a deterioratingeffect on pulmonary function. There was only positive correla-
tion between the patient’s age and PFTs. The younger the pa-
tient was, the lower the PFTs values. The strangeness of this
result would disappear when it is remembered that the pul-
monary function of patients who underwent valvular surgeries,
who were younger than patients who underwent CABG, were
of lower values.
Arabaci et al. (2003) found that after surgery PFTs values
decreased signiﬁcantly in smokers and non-smokers patients
but the deterioration in the smoker group was highly signiﬁ-
cant. In their study, patients in both groups developed a severe
restrictive pulmonary defect after coronary artery surgery
(P< 0.0001 for both), but this restriction was also statistically
signiﬁcant in the smoking group compared to non-smokers
after surgery. They applied comparison t-test between the
smokers and non-smokers but did not correlate the factor of
smoking habit with the pulmonary function as had been done
in the current study.
Since the examined intra-operative factors were not strong
enough to establish a direct correlative association with the
pulmonary function after cardiac surgery, and studying pa-
tient’s demographic characteristics did not add any further
clarity of the case, the only remaining factor is the mechanical
theory. Just approach the thoracic cage with the median ster-
notomy, the mechanics of respiration will deﬁnitely be altered
and the pulmonary function of the lungs will be negatively af-
fected. A proof of this theory is the restrictive pattern of pul-
monary function after surgery. Another proof is the fact that
most of cardiac surgery patients had atelectasis in the chest
radiographs after the surgery and this is applied to both
CABG and valvular surgeries. That is why Weissman (2004)
stated that the high incidence of pulmonary complications is
partly due to the disruption of normal pulmonary function
that is inherent to surgery in the thoracic region. Adaptation
of mechanical theory could be succeeded to rationale the de-
creased PFTs after cardiac surgery, but it could not justify
why valvular surgery was complicated with lower PFTs than
CABG surgery especially as median sternotomy was practiced
in both surgeries?
In addition, it is well known that patients after surgery are
common to have incisional chest pain that will interfere with
the ability of the chest to expand and automatically result in
low pulmonary function of restrictive pattern. That is why
when Tenenbein et al. (2008) compared between two groups
of patients who had underwent CABG, they recorded that
the group that used high epidural anaesthesia had lower pain
and higher pulmonary function than the controlled group with
the traditional analgesia morphine in the ﬁrst few days after
surgery. Not rating chest pain after the surgery was one of
the limitations of the present study. It would be helpful to
study the relation between pain after surgery, by using the vi-
sual analogue scale and the pulmonary function. The authors
also believe that another limitation is the neglection of pa-
tients’ anaesthesia data, which could be precious information
to give an explanation to the results of the study. This is espe-
cially because the effect of anaesthesia is well documented in
many other studies and it could be the guilty reason of de-
creased pulmonary function after cardiac surgery or at least
an adjunct factor with the mechanical one. It could be said that
pulmonary complication after cardiac surgery is a multifacto-
rial phenomenon and that statistical treatment of those suspi-
cious factors with multivariate approach would be more
86 S.B. El-Sobkey, M. Gomaapracticable and would provide a rational valid explanation to
that phenomenon.
5. Conclusion
Itwas concluded that rheumatic and ischemic cardiac diseases as
well as valvular and CABG cardiac surgeries result in low PFTs
values of restrictive pattern. It was documented that valvular
surgery patients had lower PFTs values than CABG surgery pa-
tients. No deﬁnite causative factor appeared to be responsible
for those results although mechanical deﬁciency and incisional
chest pain caused by cardiac surgery are doubtful. More com-
prehensive investigation is required to resolve the case.
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